Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Assisted Reproductive Technology market. The report considers the 2019-2022 historic period, 2023 as base year, and 2024-2034 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition.
Assisted Reproductive Technology market report is based on robust research methodology designed using blend of research approaches developed using secondary/desk research and validated through primary research and expert insights. Eternity Insights also uses paid databases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Assisted Reproductive Technology market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Assisted Reproductive Technology products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Assisted Reproductive Technology products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Assisted Reproductive Technology market.
To learn more about this report
Increasing research and development spending on Assisted Reproductive Technology development has been the leading industry trend of Assisted Reproductive Technology market
The leading players in the market are focused on developing products which are cost-effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be witnessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
Report Attributes | Details |
The market size value in 2023 | USD XX.XX Million |
CAGR (2023 - 2034) | XX.XX % |
The Revenue forecast in 2034 | USD XX.XX Million |
Base year for estimation | 2023 |
Historical data | 2019-2022 |
Forecast period | 2024-2034 |
Quantitative units |
|
Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered | By Type Outlook, End-User Outlook, Regional Outlook |
By Type Outlook | Media, Catheters, Needles, Product, Vitrification devices, Incubators, Other |
By End-User Outlook | Hospitals, Fertility clinics, Hospitals, Other |
Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
Key companies profiled | Merck KGaA, MISTRAL FERTILITY CLINICS S.L., NidaCon International AB, Sumitomo Mitsui Financial Group, Inc., The Cooper Companies, Inc., Thermo Fisher Scientific Inc., Vitrolife Group, Western Fertility Institute |
Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Assisted Reproductive Technology Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Assisted Reproductive Technology Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Assisted Reproductive Technology Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 General
4.2.2 Fertility Medication
4.2.3 In Vitro Fertilization
4.2.4 Others
4.4 Type Comparison Matrix
4.5 Global Assisted Reproductive Technology Market Attractiveness, By Type
5 Global Assisted Reproductive Technology Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Fertility Clinics
5.3.2 Hospitals
5.3.3 Others
5.4 Application Comparison Matrix
5.5 Global Assisted Reproductive Technology Market Attractiveness, by Application
6 Global Assisted Reproductive Technology Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Assisted Reproductive Technology Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Assisted Reproductive Technology Market Attractiveness, by Region
8 North America Assisted Reproductive Technology Market Analysis and Forecast
8.1 Key Findings
8.2 North America Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 General
8.2.2 Fertility Medication
8.2.3 In Vitro Fertilization
8.2.4 Others
8.3 North America Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Fertility Clinics
8.3.2 Hospitals
8.3.3 Others
8.4 North America Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Assisted Reproductive Technology Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Assisted Reproductive Technology Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 General
9.2.2 Fertility Medication
9.2.3 In Vitro Fertilization
9.2.4 Others
9.3 Europe Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Fertility Clinics
9.3.2 Hospitals
9.3.3 Others
9.4 Europe Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Assisted Reproductive Technology Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Assisted Reproductive Technology Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 General
10.2.2 Fertility Medication
10.2.3 In Vitro Fertilization
10.2.4 Others
10.3 Asia Pacific Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Fertility Clinics
10.3.2 Hospitals
10.3.3 Others
10.4 Asia Pacific Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Assisted Reproductive Technology Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Assisted Reproductive Technology Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 General
11.2.2 Fertility Medication
11.2.3 In Vitro Fertilization
11.2.4 Others
11.3 Latin America Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Fertility Clinics
11.3.2 Hospitals
11.3.3 Others
11.4 Latin America Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Assisted Reproductive Technology Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Assisted Reproductive Technology Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 General
12.2.2 Fertility Medication
12.2.3 In Vitro Fertilization
12.2.4 Others
12.3 Middle East & Africa (MEA) Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Fertility Clinics
12.3.2 Hospitals
12.3.3 Others
12.4 Middle East & Africa (MEA) Assisted Reproductive Technology Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Assisted Reproductive Technology Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Vitrolife
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Ferring Pharmaceuticals
13.3.3 Irvine Scientific
13.3.4 Cook Medical
13.3.5 CellCura
13.3.6 EMD Serono
13.3.7 Esco Micro
13.3.8 IKS International (Gonagen Medikal)
13.3.9 INVO Bioscience
13.3.10 IVFtech
13.3.11 Smiths Medical
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing